Bluejay Diagnostics Enrolls 545 Patients In SYMON II Study And Reports Manufacturing Readiness Progress Including Antibody Supply For Over 10M Test Cartridges Into 2026
Bluejay Diagnostics, Inc. +1.08%
Bluejay Diagnostics, Inc. BJDX | 1.88 | +1.08% |
Bluejay Diagnostics Enrolls 545 Patients In SYMON II Study And Reports Manufacturing Readiness Progress Including Antibody Supply For Over 10M Test Cartridges Into 2026
